aprindine has been researched along with Obesity in 1 studies
Aprindine: A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakanishi, T | 1 |
| Yoshimura, M | 1 |
1 review available for aprindine and Obesity
| Article | Year |
|---|---|
[Recent progress in Holter electrocardiography, focussed on heart rate variability].
Topics: Adult; Anti-Anxiety Agents; Aprindine; Autonomic Nervous System; Benzodiazepines; Caffeine; Electroc | 1993 |